2-phenylethyl 3-(3,4-dihydroxyphenyl)propanoate

• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 英文名称: 2-phenylethyl 3-(3,4-dihydroxyphenyl)propanoate
• 英文别名: phenethyl 3-(3,4-dihydroxyphenyl)propanoate；phenethyl-3-(3,4-dihydroxyphenyl)propanoate
• 化学式: C₁₇H₁₈O₄
• 分子量: 286.328
• InChiKey: HRJHXJRZYZYNAT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  21
• 可旋转键数：
  7
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.24
• 拓扑面积：
  66.8
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  咖啡酸苯乙酯 在 palladium on activated charcoal 氢气 作用下， 以 乙醇 为溶剂， 反应 4.0h， 以25%的产率得到2-phenylethyl 3-(3,4-dihydroxyphenyl)propanoate
  参考文献：
  名称：

  咖啡因和二氢咖啡酸的酯的毒性机理。

  摘要：

  最近已合成了咖啡酸和二氢咖啡酸的十种酯。这些酯对培养中的L1210白血病和MCF-7乳腺癌细胞的细胞毒性评估已导致每个系列的QSAR均存在明显差异。二氢咖啡因酸酯的L1210 QSAR与简单酚和雌激素酚获得的QSAR相似。但是，与咖啡酸酯有关的QSAR与它的姊妹QSAR有很大不同。该差异可以归因于侧链中烯烃键的存在。咖啡酸的辛酯对白血病细胞的毒性是广泛研究的苯乙酯CAPE的十倍。

  DOI：

  10.1016/s0968-0896(00)00238-8

文献信息

• Synthesis and Antiradical/Antioxidant Activities of Caffeic Acid Phenethyl Ester and Its Related Propionic, Acetic, and Benzoic Acid Analoguesc
  作者：Luc LeBlanc、Aurélie Paré、Jacques Jean-François、Martin Hébert、Marc Surette、Mohamed Touaibia

  DOI：10.3390/molecules171214637

  日期：——

  Caffeic acid phenethyl ester (CAPE) is a bioactive component isolated from propolis. A series of CAPE analogues was synthesized and their antiradical/antioxidant effects analyzed. The effect of the presence of the double bond and of the conjugated system on the antioxidant effect is evaluated with the analogues obtained from 3-(3,4-dihydroxyphenyl) propanoic acid. Those obtained from 2-(3,4-dihydroxyphenyl)

  咖啡酸苯乙酯 (CAPE) 是一种从蜂胶中分离出来的生物活性成分。合成了一系列 CAPE 类似物并分析了它们的抗自由基/抗氧化作用。双键和共轭体系的存在对抗氧化作用的影响用从3-(3,4-二羟基苯基)丙酸获得的类似物进行评价。那些从 2-(3,4-二羟基苯基) 乙酸和 3,4-二羟基苯甲酸获得的物质可以评估羰基和芳族体系之间存在两个碳的影响。
• Sinapic acid phenethyl ester as a potent selective 5-lipoxygenase inhibitor: Synthesis and structure-activity relationship
  作者：Mohamed Touaibia、Martin J. G. Hébert、Natalie A. Levesque、Jérémie A. Doiron、Marco S. Doucet、Jacques Jean-François、Marc Cormier、Luc H. Boudreau、Marc E. Surette

  DOI：10.1111/cbdd.13360

  日期：2018.11

  inhibitors is highly demanded. The action of several phenolic acid phenethyl esters as potential 5‐Lipoxygenase (5‐LO) inhibitors has been investigated. For this purpose, a series of 14 phenethyl esters was synthesized and their impact on 5‐LO inhibition was evaluated. The effects of position and number of hydroxyl and methoxy groups on the phenolic acid were investigated. The shortening of the linker between

  由于肝毒性和齐留通（Zyflo的不利的药物代谢动力学曲线®），目前唯一批准用于临床5-脂氧合酶（5-LO）抑制剂，有效和安全的5-LO抑制剂的研究是非常需要的。已经研究了几种酚酸苯乙酯作为潜在的5-Lipoxygenase（5-LO）抑制剂的作用。为此目的，合成了一系列14种苯乙酯，并评估了它们对5-LO抑制的影响。研究了羟基和甲氧基的位置和数量对酚酸的影响。还研究了羰基和邻苯二酚部分之间连接基的缩短以及α，β-不饱和羰基的存在。芥子酸苯乙酯（10）（类似于咖啡酸苯乙酯（CAPE））可以命名为SAPE（10），它以浓度依赖的方式抑制5-LO，并且优于zileuton（1）和CAPE（2）。随着集成电路的50 0.3μ的米，SAPE（10）有三个比CAPE（更有效2）和10倍齐留通（更有效1），批准用于临床使用的唯一5-LO抑制剂。与CAPE（2）不同，SAPE（10）对12-脂氧合酶（12
• Antioxidants
  申请人：Rudolph Thomas

  公开号：US20080152603A1

  公开（公告）日：2008-06-26

  The present invention relates to the use of compounds of the formula (I), with radicals defined in the description, as antioxidants, to corresponding novel compounds and compositions, and to corresponding processes for the preparation of compounds and compositions.

  本发明涉及使用式(I)中定义的基团化合物作为抗氧化剂，涉及对应的新型化合物和组合物，以及制备这些化合物和组合物的对应过程。
• Uv Protection
  申请人：Rudolph Thomas

  公开号：US20080171004A1

  公开（公告）日：2008-07-17

  The present invention relates to the use of compounds which do not themselves exhibit significant UV absorption in the UV-A or UV-B region, but are reactive under use conditions, for the development of UV-A or UV-B protection during use, to corresponding novel compounds and compositions, and to corresponding processes for the preparation of compounds and compositions.

  本发明涉及使用那些本身在UV-A或UV-B区域不表现出显著UV吸收但在使用条件下具有反应性的化合物用于开发UV-A或UV-B保护，以及相应的新化合物和组合物，以及制备化合物和组合物的相应过程。
• Hydroxylated Aromatic Inhibitors of HIV-1 Integrase
  作者：Terrence R. Jr. Burke、Mark Fesen、Abhijit Mazumder、Jessie Yung、Jian Wang、Adelaide M. Carothers、Dezider Grunberger、John Driscoll、Yves Pommier、Kurt Kohn

  DOI：10.1021/jm00021a006

  日期：1995.10

  Efficient replication of HIV-1 requires integration of a DNA copy of the viral genome into a chromosome of the host cell. Integration is catalyzed by the viral integrase, and we have previously reported that phenolic moieties in compounds such as flavones, caffeic acid phenethyl ester (CAFE, 2), and curcumin confer inhibitory activity against HIV-1 integrase. We now extend these findings by performing a comprehensive structure-activity relationship using CAPE analogues. Approximately 30 compounds have been prepared as HIV integrase inhibitors based on the structural lead provided by CAPE, which has previously been shown to exhibit an IC50 value of 7 mu M in our integration assay. These analogues were designed to examine specific features of the parent CAFE structure which may be important for activity. Among the features examined for their effects on inhibitory potency were ring substitution, side chain length and composition, and phenyl ring conformational orientation. In an assay which measured the combined effect of two sequential steps, dinucleotide cleavage and strand transfer, several analogues have IC50 values for 3'-processing and strand transfer lower than those of CAFE. Inhibition of strand transfer was assayed using both blunt-ended and ''precleaved'' DNA substrates. Disintegration using an integrase mutant lacking the N-terminal zinc finger and C-terminal DNA-binding domains was also inhibited by these analogues, suggesting that the binding site for these compounds resides in the central catalytic core. Several CAFE analogues were also tested for selective activity against transformed cells. Taken together, these results suggest that the development of novel antiviral agents for the treatment of acquired immune deficiency syndrome can be based upon inhibition of HIV-1 integrase.